1 Although RSV can affect both adults and infants, the majority of general awareness and understanding is on paediatric cases, despite evidence showing a significant impact on those aged 65+ years ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., particularly those 60 and older. Before respiratory syncytial virus (RSV) ...

When you get stuffy and come down with a nasty cough, you might assume the culprit is the common cold. Feeling seriously unwell could point you in the direction of the flu, COVID-19, or RSV ...

Lots of adults ... that appear on Sound Of are all hand-picked by a panel of impartial music industry experts from around the world and we can now reveal the longlist for 2021 For fans of ...

In a phase 3, double-blinded, placebo-controlled trial (ClinicalTrials.gov Identifier: NCT05070546), researchers evaluated the safety and immunogenicity of an RSV vaccine (Ad26/protein preF). The ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first ... The study duration was from August 2021 to December 2023. The vaccine contains ...

The adult population is a much bigger market for a potential RSV vaccine however, and accounts for the bulk of GSK's predictions of $4 billion in peak sales for its jab.